Shire Human Genetic Therapies Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Chineham, Eng UK
Total Funding:N/A
Industry:Biotech
Founded:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Shire Human Genetic Therapies's estimated annual revenue is currently $9M per year.
  • Shire Human Genetic Therapies's estimated revenue per employee is $155,000

Employee Data

  • Shire Human Genetic Therapies has 58 Employees.
  • Shire Human Genetic Therapies grew their employee count by 7% last year.
  • Shire Human Genetic Therapies currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$46.5M300N/AN/A-N/A
#2
$29.1M188N/AN/A-N/A
#3
$16.7M108N/AN/A-N/A
#4
$35.7M230N/AN/A-N/A
#5
$26.8M173N/AN/A-N/A
#6
$58.9M380N/AN/A-N/A
#7
$20.2M130N/AN/A-N/A
#8
$23.7M153N/AN/A-N/A
#9
$21.7M140N/AN/A-N/A
#10
$24.8M160N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

keywords:N/A

58

Number of Employees

$9M

Revenue (est)

1

Current Jobs

7%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Shire Human Genetic Therapies News

12-Sep-19 - Gaucher Disease Treatment Market Focusing on Global Trends and Forecast to 2025| Sonafi (Genzyme Corporation), Pfizer Inc., Acetelion Pharmaceutical (J&J Ltd.), Shire Human Genetics Therapies

... and Forecast to 2025| Sonafi (Genzyme Corporation), Pfizer Inc., Acetelion Pharmaceutical (J&J Ltd.), Shire Human Genetics Therapies.

12-Sep-19 - Gaucher Disease Treatment Market to Record an Exponential CAGR by 2025

Enzyme replacement therapy has widely improved the quality of life for ... GlaxoSmithKline (GSK), Pfizer Inc., Shire Human Genetic Therapies, ...

31-Aug-19 - Understand the demand for Gaucher Disease Treatment Market 2019 Forecast to 2026 By Top Key Players – Abbott, Aptalis Pharma, Genzyme Corporation, GlaxoSmithKline (GSK), Pfizer Inc, Shire Human

Abbott, Aptalis Pharma, Genzyme Corporation, GlaxoSmithKline (GSK), Pfizer Inc, Shire Human Genetic Therapies, Eli Lilly and Company, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$469.1M1538N/AN/A-N/A